DIASTAT® AcuDial™ (diazepam rectal gel) can help complete your patients’ plan.

DIASTAT AcuDial is the first and only FDA-approved, acute at-home treatment for patients two years and older on stable anti-epileptic medications (AEDs) who experience bouts of increased seizure activity. Learn more about DIASTAT AcuDial.

Patients need a plan that works in emergency situations1.

DIASTAT AcuDial offers precise dosing options determined by age and weight2. DIASTAT AcuDial provides rapid, reliable treatment wherever it is needed. Learn more about individualized dosing.

 
The 20mg DIASTAT AcuDial syringe has been modified for the sake of simplification and to minimize potential dosing errors. Learn more.
 
 Preparation is critical1 as more than 30% of seizures are not controlled by AEDs alone3. A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty. Download a plan now.
 
 


DIASTAT AcuDial syringes may contain cracks at the base of the syringe tips
  • It is critical you advise your patients to inspect their DIASTAT AcuDial syringes now and re-inspect them frequently
  • Advise patients to return any product with a cracked tip to the pharmacy for replacement
  • Advise patients — DO NOT completely remove the cap while inspecting for cracked tips

Learn more about how to properly inspect the syringes:

If you are unable to download the instructions or have additional questions, please call 1-877-361-2719
 
References:
  1. Pellock JM, Marmarou A, DeLorenzo R. Time to treatment in prolonged seizure episodes. Epilepsy & Behav. 2004;5:192-196.
  2. DIASTAT AcuDial package insert. Aliso Viejo,Calif: Valeant Pharmaceuticals NA; Nov. 2006.
  3. Kwan P, Brodie MJ.Early identification of refractory epilepsy. N Engl J Med. 2000;342:314-319.

IMPORTANT SAFETY INFORMATION

DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.

In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.